Eliem Therapeutics Aims For $81 Million U.S. IPO
sanjeri/E+ via Getty Images
Quick Take
Eliem Therapeutics (ELYM) has filed to raise $81 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing drug candidates for treating…
